U.S., March 7 -- ClinicalTrials.gov registry received information related to the study (NCT06861647) titled 'ISITE: Investigation of Somatic Alterations in Tumours of the Eye' on Feb. 07.
Brief Summary: Modern DNA sequencing technologies enable researchers to identify mutations that have been acquired during the lifetime of patients (somatic mutations). Some of these somatic mutations occur in cancer genes and increase the risk of developing cancer. This study will apply such sequencing technologies to cancers of the eye (ocular melanoma) in order to identify mutations associated with these cancers. Sequencing patients at different stages of their disease will allows us to build a timeline of the order of mutations that occur at each stage...